{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:58:49Z","timestamp":1760403529959,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijantimicag.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T13:36:25Z","timestamp":1539178585000},"page":"95-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quantifying the importance of active antimicrobial therapy among patients with Gram-negative bloodstream infections: Cefepime as a representative agent"],"prefix":"10.1016","volume":"53","author":[{"given":"Cristina","family":"Miglis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0018-5434","authenticated-orcid":false,"given":"N.J.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-6130","authenticated-orcid":false,"given":"M.H.","family":"Scheetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0001","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/clinids\/10.1.203","article-title":"Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis","volume":"10","author":"Gatell","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0003","first-page":"35","article-title":"The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults","volume":"5","author":"Weinstein","year":"1983","journal-title":"I. Laboratory and epidemiologic observations. Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1378\/chest.100.1.164","article-title":"Excess mortality in critically ill patients with nosocomial bloodstream infections","volume":"100","author":"Smith","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0005","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/JCM.41.8.3655-3660.2003","article-title":"Epidemiology and outcome of nosocomial and community-onset bloodstream infection","volume":"41","author":"Diekema","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0006","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/AAC.01956-15","article-title":"Defining clinical exposures of cefepime for Gram-negative bloodstream infections that are associated with improved survival","volume":"60","author":"Rhodes","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0007","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijantimicag.2017.04.023","article-title":"Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia: a 'Goldilocks' window","volume":"50","author":"Miglis","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0008","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1378\/chest.100.6.1619","article-title":"The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults","volume":"100","author":"Knaus","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0009","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2015.03.005","article-title":"Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC","volume":"82","author":"Rhodes","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0010","first-page":"4","article-title":"APACHE-II score correlation with mortality and length of stay in an intensive care unit","volume":"21","author":"Naved","year":"2011","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.ijantimicag.2018.10.004_bib0011","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2110-5820-2-37","article-title":"Continuous \u03b2-lactam infusion in critically ill patients: the clinical evidence","volume":"2","author":"Abdul-Aziz","year":"2012","journal-title":"Ann Intensive Care"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:33:11Z","timestamp":1760376791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918302966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0924857918302966"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.10.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying the importance of active antimicrobial therapy among patients with Gram-negative bloodstream infections: Cefepime as a representative agent","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}